8
Views
15
CrossRef citations to date
0
Altmetric
Original Article

A Hypothesis Regarding the Function of Angiotensin Peptides in the Brain

, , , , , & show all
Pages 107-121 | Published online: 03 Jul 2009

References

  • Page I. H. Hypertension Mechanisms. Grune and Stratton, Inc., Orlando, New York 1987; 362
  • Harding J. W., Felix D. Angiotensin-sensitive neurons in the rat paraventricular nucleus: relative potencies of angiotensin II and angiotensin III. Brain Res 1987; 410: 130–134
  • Fink G. D., Bruner C. A. Hypertension during chronic peripheral and central infusion of angiotensin III. Am J Physiol 1985; 249: E201–208
  • Khosla M. C., Smeby R. R., Bumpus F. M. Structure-activity relationship in angiotensin II analogs. Angiotensin, I. H. Page, F. M. Bumpus. Springer-Verlag, Berlin 1974; 126–161
  • Yang H. Y.T., Erdos E. G., Chiang T. S. New enzymatic route for the inactivation of angiotensin. Nature 1968; 218: 1224–1226
  • Regoli D., Park W. K., Rioux F., Magnan J. Metabolism of angiotensin in vascular smooth muscle. Biologically Active Peptides, R. Waher, J. Meienh. Ann Arbor Sci. Publishers, Inc., Ann Arbor, MI 1975; 617–624
  • Tonnaer J. A., Wiegant V. M., DeJong W., DeWied D. Central effects of angiotensins on drinking and blood pressure: structure activity relationships. Brain Res 1982; 236: 417–428
  • Tonnaer J. A., Engels G. M., Wiegant V. M., Burbach J. P., DeJong W., DeWied D. Conversion of angiotensins in rat brain tissue. Eur J Biochem 1983; 131: 415–421
  • Allard M., Simonnet G., Dupouy B., Vincent J. D. Angiotensin II inactivation process in cultured mouse spinal cord cells. J Neurochem 1987; 48: 1553–1559
  • Greene L. J., Spadaro A. C.C., Martin A. R., Perussi De Jesus W. D., Camargo A. C.M. Brain endo-oligopeptidase B: A post-proline cleaving enzyme that inactivates angiotensin I and II. Hypertension 1982; 4: 178–184
  • Schiavone M. T., Santos R. A.S., Brosnihan K. B., Khosla M. C., Ferrario C. M. Release of vasopressin from the rat hypothalamo-neurohypophysial system by the angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci 1988; 85: 4095–4098
  • Ferrario C. M., Averill D. B., Barnes K. L., Block C. H., Diz D. I. Role of the area postrema pressor mechanisms in the regulation of arterial blood pressure. Can J Physiol Pharmacol 1987; 65: 1591–1597
  • Mikami H., Suzuki H., Ferrario C. M. Cerebrospinal fluid angiotensin II immunoreactivity is not derived from the plasma. Hypertension 1985; 7: 65–71
  • Suzuki H., Ferrario C. M., Speth R. C., Brosnihan K. B., Smeby R. R., DeSilva P. Alterations in plasma and cerebrospinal fluid norepinephrine and angiotensiu II during the development of renal hypertension in conscious dogs. Hypertension 1983; 5(Suppl I)I-139–I-148
  • Suzuki H., Saruta T., Ferrario C. M. Changes in central and peripheral reninangiotensin system after furosemide injection. Endocrinol Japon 1986; 33: 497–503
  • Suzuki H., Smeby R. R., Mikami H., Brosnihan K. B., DeSilva P., Saruta T., Ferrario C. M. Nonrenal factors contribute to plasma and cerebrospinal fluid angiotensin II. Hypertension 1986; 8(Suppl I)I-95–I-100
  • Smeby R. R., Husain A. Angiotensin I and II forming enzymes in the central nervous system. Brain Peptides and Catecholamines in Cardiovascular Regulation in Normal and Disease States, C. M. Ferrario, J. P. Buckley. Raven Press, New York 1987
  • Bridle P. A., Brosnihan K. B., Husain A., Smeby R. R., Howard R., Ferrario C. M. Microregional distribution of renin activity within catecholamine-containing medullary and forebrain regions of the dog brain. Neurosci Abstr 1986; 12: 1332
  • Santos R. A.S., Brosnihan K. B., Chappell M. C., Pesquero J., Chernicky C. L., Greene L. J., Ferrario C. M. Converting enzyme activity and angiotensin metabolism in the dog brain stem. Hypertension 1988; 11(Suppl I)I-153–I-157
  • Barnes K. L., Chernicky C. L., Block C. H., Ferrario C. M. Distribution of catecholaminergic neuronal systems in the canine medulla oblongata and pons. J Comp Neurol 1988, In press
  • Chappell M. C., Brosnihan K. B., Welches W. R., Ferrario C. M. Characterization by high performance liquid chromatography of angiotensin peptides in the plasma and cerebrospinal fluid of the dog. Peptides 1987; 8: 939–942
  • Sladek C. D. Regulation of vasopressin release by neurotransmitters, neuropeptides and osmotic stimuli. The Neurohypophysis: Structure, Function and Control, B. A. Cross, G. Leng, 1983; 60: 71–90, Prog. in Brain Res.
  • Schiavone M. T., Brosnihan K. B., Husain A., Ferrario C. M. Basal and potassium-evoked release of angiotensin II from the rat hypothalamus. Brain Res 1986; 387: 193–196
  • Block C. H., Santos R. A.S., Brosnihan K. B., Vilsack H., Chappell M., Khosla M., Ferrario C. M. Immunocytochemical localization of angiotensin-(1-7) in the rat hypothalamus. Endocrine Society 1988; 70: 313
  • Santos M. J.C., Santos R. A.S., Diz D. I., Khosla M. C., Ferrario C. M. Cardiovascular actions of angiotensin-(1-7) microinjected into the dorsomedial medulla (DMM). Faseb Journal 1988; 2: 1487
  • Campbell D. J. The site of angiotensin production. J Hypertens 1985; 3: 199–207
  • Printz M. P., Chen F. M., Slivka S., Maciejewski A. R. Comparison of neural and peripheral angiotensin II receptors. Brain Peptides and Catecholamines in Cardiovascular Regulation, J. P. Buckley, C. M. Ferrario, 1987; 233–244
  • Ganten D., Hutchinson J. S., Schelling P., Ganten U., Fischer H. The isorenin angiotensin systems in extrarenal tissue. Clin Exper Pharmacol Physiol 1976; 3: 103–106
  • Ferrario C. M., Ueno Y., Diz D. I., Barnes K. L. The renin-angiotensin system: physiological actions on the central nervous system. Handbook of Hypertension, W. H. Birkenhager, J. L. Reid. Elsevier/North Holland Biomedical Press, AmsterdamThe Netherlands 1986; 431–454
  • Ryan J. W. The fate of angiotensin II. Angiotensin, I. H. Page, F. M. Bumpus. Springer-Verlag, Berlin 1974; 81–110
  • Andrews P., Hines C., Dixon J. Characterization of proline endopeptidase from rat brain. Biochem. 1980; 19: 5494–5500
  • Orlowski M., Wilk S. Purification and specificity of a membrane-bound metalloendopeptidase from bovine pituitaries. Biochemistry 1981; 20: 4942–4950
  • Skidgel R. A., Engelbrecht S., Johnson A. R., Erdos E. G. Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides 1984; 5: 769–776
  • Sullivan S., Akil H., Barchas J. D. In vivo degradation of enkephalin: evidence for cleavage at the Gly-Phe bond. Commun. Psychopharmacol. 1978; 2: 525
  • Checler F., Amar F., Kitabgi P., Vincent J. Metabolism of neurotensin by neural (neuroblastoma NIE 115) and extraneural (HT29) cell lines. Peptides 1986; 7: 1071–1077
  • Welches W. R., Santos R. A.S., Brosnihan K. B., Chappell M. C., Ferrario C. M. Evidence for a role of prolylendopeptidase in the angiotensin I metabolism in dog hypothalamus. Endocrine Society 1988
  • Friedman T. C., Orlowski M., Wilk S. Prolyl endopeptidase: Inhibition in vivo by N-benzyloxycarbonyl-prolyl-prolinal. J. Neurochem. 1984; 42: 237–241
  • Maggio J. E. Tachykinins. Ann. Rev. Neurosci. 1988; 11: 13–28
  • Lind R. W., Swanson L. W., Bruhn T. O., Ganten D. The distribution of angiotensin II-immunoreactive cells and fibers in the paraventriculo-hypophysial system of the rat. Brain Res. 1985; 338: 81–89

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.